COVAXIN
Latest news and video coverage curated from trusted media outlets
0 shares | ShareTweetSavePostSend |
Which is the Best Covid Vaccine? II Covishield vs Covaxin vs Sputnik-V II FAQs Covid 19 Vaccine Credit: Rumble Duration: 10:44Published | |
You Might Like
1 in 3 Covaxin recipients hit by adverse events: StudyNearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..IndiaTimes - Published | |
Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: StudyBharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable..IndiaTimes - Published | |
Over 30% Covaxin takers suffered from health issues after 1 year: ReportA study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI). Among 926 participants, viral upper..IndiaTimes - Published | |
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effectsFollowing AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer..IndiaTimes - Published | |
What to watch on OTT this weekExplore a diverse range of content on OTT this week, from the hilarious banter of Koffee with Karan featuring Varun Dhawan and Sidharth Malhotra to the emotional rollercoaster of 'Aam Aadmi Family'..IndiaTimes - Published | |
The Vaccine War script to be a featured in Oscar libraryVivek Agnihotri helmed 'The Vaccine War' has been invited by the Academy for their library. The Academy of Motion Picture Arts and Sciences reached out to the filmmaker, expressing interest in..IndiaTimes - Published | |
Vivek announces BOGO for The Vaccine WarVivek Agnihotri, director of 'The Vaccine War,' has announced a 'buy 1 get 1' ticket offer for the movie. The film has been doing well at the box office and Agnihotri wants to show appreciation to the..IndiaTimes - Published | |
The Vaccine War struggles at the BODirected by Vivek Agnihotri, The Vaccine War is based on the book ‘Going Viral’ by Prof Balram Bhargava, Director General – Indian Council of Medical Research (ICMR). It talks about the..IndiaTimes - Published | |
The Vaccine War BO day 1: the movie starts slow'The Vaccine War' is touted to be India’s first ‘bio-science’ film as it tries to present the story of the scientists who developed India’s Covid-19 vaccine, Covaxin, during the pandemic.IndiaTimes - Published | |
Covovax for adults to reach metros in a week: SIISerum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..IndiaTimes - Published | |
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseCovovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..IndiaTimes - Published | |
Amid rising viral cases, Bharat Biotech working on H3N2 vaccineAmid rising cases of H3N2 influenza virus in the country and reports of some deaths too, Hyderabad-based vaccine maker Bharat Biotech, which developed the indigenous Covaxin and intranasal vaccine..IndiaTimes - Published | |
Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsCovid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two..Zee News - Published | Drug panel favours nod for Covovax as Covid boosterAn expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..IndiaTimes - Published |
Covovax may get approval as heterologous boosterThe government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..IndiaTimes - Published | Ocugen announces positive top-line data for Covaxin in US trialsnewKerala.com - Published |
Delhi HC makes Bharat Biotech, Centre parties in pleas seeking details on CovaxinnewKerala.com - Published | Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trialOcugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name..IndiaTimes - Published |
Covid-19: Vaccination figures jump three-fold in MumbaiGovt-run centres only have Covaxin; state writes to Centre seeking Covishield, CorbevaxMid-Day - Published | Bharat Biotech's nasal vaccine to be priced at Rs 800/dose in pvt markets, Rs 325/dose for governmentsBharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for central and state governments. The company..IndiaTimes - Published |
Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are availableNoida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.DNA - Published | Explained: Covid-19 nasal vaccine available now, know how it works and who can takeThe nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.DNA - Published |
Mumbai: No takers, no stock for Covid-19 vaccinesWith interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin leftMid-Day - Published | Government rejects claims of rushed approval for Covaxin due to 'political pressure'newKerala.com - Published |
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'newKerala.com - Published | No external pressure to accelerate Covaxin development: Bharat BiotechnewKerala.com - Published |
`Misleading, fallacious`: Govt rubbishes media reports claiming Covaxin approval due to political pressureThe Central Drugs Standard Control Organization's Subject Expert Committee met on January 1 and 2, 2021 and made recommendations on Bharat Biotech's proposal for Restricted Emergency Approval of the..Zee News - Published | Indian govt, Bharat Biotech rubbish reports of Covaxin development being rushed under political pressureIndiaTimes - Published |
Govt: Sputnik V recipients can take Covishield, Covaxin boosterIndiaTimes - Published | India widens Covid-19 vaccine basket, Corbevax to be available as booster dose for all adults from THIS dateThose adults who got vaccinated with either Covaxin or Covishield will now be allowed to take the Corbevax dose, six months or 26 weeks after administration of the second dose.Zee News - Published |
Corbevax approved as precaution dose for adults vaccinated with Covaxin, CovishieldnewKerala.com - Published Also reported by •Indian Express •DNA •Zee News •IndiaTimes | Corbevax gets nod as booster after Covishield, Covaxin shotsIndiaTimes - Published |
India to start Covid mix-and-match booster vaccines on FridayIndia said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..IndiaTimes - Published | Mix and match: Centre okays Corbevax as booster for those who got Covishield or CovaxinIndian Express - Published Also reported by •IndiaTimes |
Biological E's Corbevax gets go ahead for use as booster for Covaxin, CovishieldIn what is the first heterologous booster shot to be approved, Biological E’s Covid-19 vaccine Corbevax is learnt to have received the government’s nod for use as a booster or precaution dose for..IndiaTimes - Published | Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soonIndian Express - Published Also reported by •IndiaTimes |
Japan approves COVAXIN booster dose for travellers: Bharat BiotechnewKerala.com - Published | Japan allows Covaxin boosted travellers to visit countryIndiaTimes - Published |
Covid-19: Covaxin booster has 77.8 per cent efficacy against variantsHealth experts say the study has put the indigenous vaccine among global ones, but add that it needs long-term studiesMid-Day - Published | Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat BiotechnewKerala.com - Published Also reported by •IndiaTimes |
Covaxin can help control virus load, reduce disease severity: StudynewKerala.com - Published | Covaxin booster dose safe, ensures persistent immunity to minimise breakthrough Covid infections: StudyIndian Express - Published |
NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: SourcesnewKerala.com - Published |